Increased Feasibility of Weekly Epirubicin and Paclitaxel as Neoadjuvant Chemotherapy for Locally Advanced Breast Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|28|6-7|339-344

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.28, Iss.6-7, 2005-06, pp. : 339-344

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial in Japan of Sequential Administration of Weekly Paclitaxel Followed by FEC as Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer [KBCSG0206 Trial: Kinki Breast Cancer Study Group (KBCSG)]

By  

Oncology, Vol. 78, Iss. 5-6, 2010-07 ,pp. : 302-308

Karger

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy with Cyclophosphamide, Mitoxantrone, and 5-Fluorouracil in Locally Advanced Breast Cancer

By  

Oncology Research and Treatment, Vol. 28, Iss. 2, 2005-01 ,pp. : 81-85

Karger

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy with Sequential Methotrexate and 5-Fluorouracil Scheduling, Epirubicin and Cisplatin for Locally Advanced Bladder Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 1-5

Karger

Access to resources Recommend Favorite

Intensified Neoadjuvant Chemotherapy with Nab-Paclitaxel plus Gemcitabine Followed by FOLFIRINOX in a Patient with Locally Advanced Unresectable Pancreatic Cancer

By  

Case Reports in Oncology, Vol. 7, Iss. 3, 2014-09 ,pp. : 648-655

Karger

Access to resources Recommend Favorite

Neoadjuvant and Adjuvant Chemotherapy of Locally Advanced Stomach Cancer

By  

Oncology Research and Treatment, Vol. 24, Iss. 2, 2001-05 ,pp. : 116-121

Karger

Access to resources Recommend Favorite